Aurinia Pharmaceuticals, created in 1993 (Canada), from 2214 competing brands. The Aurinia Pharmaceuticals brand is owned by Aurinia Pharmaceuticals, a company listed in Francfort. Its International Securities Identification Number (ISIN) is CA05156V1022. Aurinia Pharmaceuticals belongs to the Biotechnology business sector.

Aurinia Pharmaceuticals is a brand of Aurinia Pharmaceuticals (IKAP) Share price

Date created : 1993 Business sector Biotechnology

Share price and profitability of the share Aurinia Pharmaceuticals (Aurinia Pharmaceuticals)

Buy Aurinia Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested EUR 4.58

Portfolio valuation
Aurinia Pharmaceuticals over 5 years* EUR 3.77

Stock market history Aurinia Pharmaceuticals

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Aurinia Pharmaceuticals

See more brands of Aurinia Pharmaceuticals

Rival brands
Aurinia Pharmaceuticals

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS